BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xin L, Zhou Q, Yuan YW, Zhou LQ, Liu L, Li SH, Liu C. METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy. J Cancer Res Clin Oncol 2019;145:2507-17. [PMID: 31485766 DOI: 10.1007/s00432-019-03015-w] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Kumar A, Girisa S, Alqahtani MS, Abbas M, Hegde M, Sethi G, Kunnumakkara AB. Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics. Cells 2023;12. [PMID: 36899946 DOI: 10.3390/cells12050810] [Reference Citation Analysis]
2 Long X, Yan J, Zhang Z, Chang J, He B, Sun Y, Liang Y. Autophagy-targeted nanoparticles for effective cancer treatment: advances and outlook. NPG Asia Mater 2022;14. [DOI: 10.1038/s41427-022-00422-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Roh J, Im M, Chae Y, Kang J, Kim W. The Involvement of Long Non-Coding RNAs in Glutamine-Metabolic Reprogramming and Therapeutic Resistance in Cancer. Int J Mol Sci 2022;23. [PMID: 36499136 DOI: 10.3390/ijms232314808] [Reference Citation Analysis]
4 Li J, Li X, Guo Q. Drug Resistance in Cancers: A Free Pass for Bullying. Cells 2022;11:3383. [DOI: 10.3390/cells11213383] [Reference Citation Analysis]
5 Wang Z, Liu J, Xie J, Yuan X, Wang B, Shen W, Zhang Y. Regulation of autophagy by non-coding RNAs in gastric cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.947332] [Reference Citation Analysis]
6 Zhang L, Ye B, Chen Z, Chen Z. Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.10.002] [Reference Citation Analysis]
7 Zhang C, Kang T, Wang X, Wang J, Liu L, Zhang J, Liu X, Li R, Wang J, Zhang J. LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation via epigenetic silencing of ATG5 by EZH2. Front Pharmacol 2022;13:968223. [DOI: 10.3389/fphar.2022.968223] [Reference Citation Analysis]
8 Lu L, Liang Q, Zhang X, Xu Y, Meng D, Liang Z. Autophagy Related Noncoding RNAs: Emerging Regulatory Factors of Gastric Cancer. Cancer Manag Res 2022;14:2215-24. [PMID: 35898946 DOI: 10.2147/CMAR.S364761] [Reference Citation Analysis]
9 Wang Y, Liu Z, Xu Z, Shao W, Hu D, Zhong H, Zhang J. Introduction of long non-coding RNAs to regulate autophagy-associated therapy resistance in cancer. Mol Biol Rep 2022. [PMID: 35810239 DOI: 10.1007/s11033-022-07669-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li YP, Liu Y, Xiao LM, Chen LK, Tao EX, Zeng EM, Xu CH. Induction of cancer cell stemness in glioma through glycolysis and the long noncoding RNA HULC-activated FOXM1/AGR2/HIF-1α axis. Lab Invest 2022;102:691-701. [PMID: 35013529 DOI: 10.1038/s41374-021-00664-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Chen Y, Cui Z, Wu Q, Wang H, Xia H, Sun Y. Long non-coding RNA HOXA11-AS knockout inhibits proliferation and overcomes drug resistance in ovarian cancer. Bioengineered 2022;13:13893-905. [PMID: 35706412 DOI: 10.1080/21655979.2022.2086377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhu Q, Chen H, Li X, Wang X, Yan H. JMJD2C mediates the MDM2/p53/IL5RA axis to promote CDDP resistance in uveal melanoma. Cell Death Discov 2022;8:227. [PMID: 35468881 DOI: 10.1038/s41420-022-00949-y] [Reference Citation Analysis]
13 Long W, Zhang L, Wang Y, Xie H, Wang L, Yu H, Zheng D. Research Progress and Prospects of Autophagy in the Mechanism of Multidrug Resistance in Tumors. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/7032614] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Liu Y, Ao X, Wang Y, Li X, Wang J. Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance. Front Oncol 2022;12:841411. [DOI: 10.3389/fonc.2022.841411] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
15 Shafabakhsh R, Arianfar F, Vosough M, Mirzaei HR, Mahjoubin-Tehran M, Khanbabaei H, Kowsari H, Shojaie L, Azar MEF, Hamblin MR, Mirzaei H. Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance. Cancer Gene Ther 2021;28:1229-55. [PMID: 33432087 DOI: 10.1038/s41417-020-00272-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
16 Koustas E, Trifylli E, Sarantis P, Kontolatis NI, Damaskos C, Garmpis N, Vallilas C, Garmpi A, Papavassiliou AG, Karamouzis MV. The Implication of Autophagy in Gastric Cancer Progression. Life 2021;11:1304. [DOI: 10.3390/life11121304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhang YL, Ma Y, Zeng YQ, Liu Y, He EP, Liu YT, Qiao FL, Yu R, Wang YS, Wu XY, Leng P. A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics. Ann Transl Med 2021;9:1704. [PMID: 34988213 DOI: 10.21037/atm-21-5271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
18 Xin L, Lu H, Liu C, Zeng F, Yuan YW, Wu Y, Wang JL, Wu DZ, Zhou LQ. Methionine deficiency promoted mitophagy via lncRNA PVT1-mediated promoter demethylation of BNIP3 in gastric cancer. Int J Biochem Cell Biol 2021;141:106100. [PMID: 34678458 DOI: 10.1016/j.biocel.2021.106100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Li Y, Li W, Hoffman AR, Cui J, Hu JF. The Nucleus/Mitochondria-Shuttling LncRNAs Function as New Epigenetic Regulators of Mitophagy in Cancer. Front Cell Dev Biol 2021;9:699621. [PMID: 34568319 DOI: 10.3389/fcell.2021.699621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhou M, Zhang G, Hu J, Zhu Y, Lan H, Shen X, Lv Y, Huang L. Rutin attenuates Sorafenib-induced Chemoresistance and Autophagy in Hepatocellular Carcinoma by regulating BANCR/miRNA-590-5P/OLR1 Axis. Int J Biol Sci 2021;17:3595-607. [PMID: 34512168 DOI: 10.7150/ijbs.62471] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
21 Chen S, Wang W, Tan HY, Lu Y, Li Z, Qu Y, Wang N, Wang D. Role of Autophagy in the Maintenance of Stemness in Adult Stem Cells: A Disease-Relevant Mechanism of Action. Front Cell Dev Biol 2021;9:715200. [PMID: 34414192 DOI: 10.3389/fcell.2021.715200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Huang B, Wei M, Hong L. Long noncoding RNA HULC contributes to paclitaxel resistance in ovarian cancer via miR-137/ITGB8 axis. Open Life Sci 2021;16:667-81. [PMID: 34250246 DOI: 10.1515/biol-2021-0058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Zhang S, Wang L, Gao Y, Fan Y, Zhang G, Zhang Y. Molecular Mechanism of 73HOXC-AS1-Activated Wntβ-Catenin Signaling and eIF4AIII in Promoting Progression of Gastric Cancer. Biomed Res Int 2021;2021:8814843. [PMID: 33954199 DOI: 10.1155/2021/8814843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Ghafouri-Fard S, Shoorei H, Mohaqiq M, Majidpoor J, Moosavi MA, Taheri M. Exploring the role of non-coding RNAs in autophagy. Autophagy 2021;:1-22. [PMID: 33525971 DOI: 10.1080/15548627.2021.1883881] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
25 Ding Y, Tan X, Abasi A, Dai Y, Wu R, Zhang T, Li K, Yan M, Huang X. LncRNA TRPM2-AS promotes ovarian cancer progression and cisplatin resistance by sponging miR-138-5p to release SDC3 mRNA. Aging (Albany NY) 2021;13:6832-48. [PMID: 33621194 DOI: 10.18632/aging.202541] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
26 Li C, Qiu J, Xue Y. Low-dose Diosbulbin-B (DB) activates tumor-intrinsic PD-L1/NLRP3 signaling pathway mediated pyroptotic cell death to increase cisplatin-sensitivity in gastric cancer (GC). Cell Biosci 2021;11:38. [PMID: 33579380 DOI: 10.1186/s13578-021-00548-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
27 Qi Y, Yang W, Liu S, Han F, Wang H, Zhao Y, Zhou Y, Zhou D. Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT. Cancer Cell Int 2021;21:74. [PMID: 33494783 DOI: 10.1186/s12935-021-01771-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Li Z, Lü M, Zhou Y, Xu L, Jiang Y, Liu Y, Li X, Song M. Role of Long Non-Coding RNAs in the Chemoresistance of Gastric Cancer: A Systematic Review. Onco Targets Ther 2021;14:503-18. [PMID: 33500626 DOI: 10.2147/OTT.S294378] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
29 郝 亚. Autophagy-Mediated Chemotherapy Resistance of Gastric Cancer. ACM 2021;11:4499-4506. [DOI: 10.12677/acm.2021.1110660] [Reference Citation Analysis]
30 Sun T, Li K, Zhu K, Yan R, Dang C, Yuan D. SNHG6 Interacted with miR-325-3p to Regulate Cisplatin Resistance of Gastric Cancer by Targeting GITR. Onco Targets Ther 2020;13:12181-93. [PMID: 33268996 DOI: 10.2147/OTT.S262896] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
31 Xu JL, Yuan L, Tang YC, Xu ZY, Xu HD, Cheng XD, Qin JJ. The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe? Front Cell Dev Biol 2020;8:621428. [PMID: 33344463 DOI: 10.3389/fcell.2020.621428] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
32 Cai Y, Li Y, Sun B, Wang H, Zhang W, Zhao Y, Zhao H, Zhang J, Xu J, Wang Y. LncRNA PTCSC3 and lncRNA HULC Negatively Affect Each Other to Regulate Cancer Cell Invasion and Migration in Gastric Cancer. Cancer Manag Res 2020;12:8535-43. [PMID: 32982446 DOI: 10.2147/CMAR.S254944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Han M, Qian X, Cao H, Wang F, Li X, Han N, Yang X, Yang Y, Dou D, Hu J, Wang W, Han J, Zhang F, Dong H. lncRNA ZNF649-AS1 Induces Trastuzumab Resistance by Promoting ATG5 Expression and Autophagy. Mol Ther 2020;28:2488-502. [PMID: 32735773 DOI: 10.1016/j.ymthe.2020.07.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
34 Liang H, Li F, Li H, Wang R, Du M. Overexpression of lncRNA HULC Attenuates Myocardial Ischemia/reperfusion Injury in Rat Models and Apoptosis of Hypoxia/reoxygenation Cardiomyocytes via Targeting miR-377-5p through NLRP3/Caspase‑1/IL‑1β Signaling Pathway Inhibition. Immunol Invest 2020;:1-14. [PMID: 32674625 DOI: 10.1080/08820139.2020.1791178] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
35 Tan H, Zhang S, Zhang J, Zhu L, Chen Y, Yang H, Chen Y, An Y, Liu B. Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implications. Theranostics 2020;10:8880-902. [PMID: 32754285 DOI: 10.7150/thno.47548] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 12.7] [Reference Citation Analysis]
36 Nie K, Deng Z, Zheng Z, Wen Y, Pan J, Jiang X, Yan Y, Liu P, Liu F, Li P. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer. DNA Cell Biol 2020;39:1532-44. [PMID: 32644844 DOI: 10.1089/dna.2020.5565] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
37 Hu Y, Ye S, Li Q, Yin T, Wu J, He J. Quantitative Proteomics Analysis Indicates That Upregulation of lncRNA HULC Promotes Pathogenesis of Glioblastoma Cells. Onco Targets Ther 2020;13:5927-38. [PMID: 32606802 DOI: 10.2147/OTT.S252915] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
38 Yuan L, Xu ZY, Ruan SM, Mo S, Qin JJ, Cheng XD. Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance. Mol Cancer. 2020;19:96. [PMID: 32460771 DOI: 10.1186/s12943-020-01219-0] [Cited by in Crossref: 110] [Cited by in F6Publishing: 119] [Article Influence: 36.7] [Reference Citation Analysis]
39 Jiang W, Xia J, Xie S, Zou R, Pan S, Wang Z, Assaraf YG, Zhu X. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs. Drug Resistance Updates 2020;50:100683. [DOI: 10.1016/j.drup.2020.100683] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 20.3] [Reference Citation Analysis]
40 Dai Q, Zhang T, Pan J, Li C. LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway. J Cancer 2020;11:3882-92. [PMID: 32328192 DOI: 10.7150/jca.43446] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]